Angelini Chemicals
-
-
Since 1967 into API CDMO business
-
We help to make your Molecules
-
Put your chemistry in our hands
News & publications
-
Pubblicato:
HIGH-POTENT API: Strategy and Legacy
The pharmaceutical landscape is continuously evolving, driven by innovation in drug development and the growing demand for targeted therapies. High-potency active pharmaceutical ingredients (HPAPIs) have emerged as crucial components in treating diseases such as cancer and autoimmune disorders. Recognizing the increasing importance of HPAPIs, our company has strategically diversified into their production, and our extensive experience in producing traditional APIs provides a foundation for success in this new venture.
-
Pubblicato:
9th HPAPI Summit 2026
The 9th HPAPI Summit 2026 is the leading meeting for professionals in highly potent active pharmaceutical ingredients. With demand rising in oncology and targeted therapies, the summit spotlights the latest in process optimization, digital transformation, containment strategies, and global compliance.
-
Pubblicato:
CPHI Europe 2026
CPHI Milan is the most important pharmaceutical event worldwide and represents each stage of the pharmaceutical supply chain.